These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31299951)

  • 21. Plasma collagen neoepitopes are associated with multiorgan disease in the ACCESS and GRADS sarcoidosis cohorts.
    Sand JMB; Jessen H; Leeming DJ; Yu S; Lee CJ; Hu B; Sun Y; Adams T; Pivarnik T; Liu A; Woo S; McGovern JR; Fiorini V; Saber T; Higuero-Sevilla JP; Gulati M; Kaminski N; Damsky W; Shaw AC; Mohanty S; Goobie G; Zhang Y; Herzog EL; Ryu C
    Thorax; 2024 Nov; 79(12):1136-1144. PubMed ID: 39117421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.
    Chien JW; Richards TJ; Gibson KF; Zhang Y; Lindell KO; Shao L; Lyman SK; Adamkewicz JI; Smith V; Kaminski N; O'Riordan T
    Eur Respir J; 2014 May; 43(5):1430-8. PubMed ID: 24177001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
    Karsdal MA; Hjuler ST; Luo Y; Rasmussen DGK; Nielsen MJ; Holm Nielsen S; Leeming DJ; Goodman Z; Arch RH; Patel K; Schuppan D
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G25-G31. PubMed ID: 30160980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Bihlet AR; Karsdal MA; Sand JM; Leeming DJ; Roberts M; White W; Bowler R
    Respir Res; 2017 Jan; 18(1):22. PubMed ID: 28103932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
    Ohta S; Okamoto M; Fujimoto K; Sakamoto N; Takahashi K; Yamamoto H; Kushima H; Ishii H; Akasaka K; Ono J; Kamei A; Azuma Y; Matsumoto H; Yamaguchi Y; Aihara M; Johkoh T; Kawaguchi A; Ichiki M; Sagara H; Kadota JI; Hanaoka M; Hayashi SI; Kohno S; Hoshino T; Izuhara K;
    PLoS One; 2017; 12(3):e0174547. PubMed ID: 28355256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
    Ferreira JP; Butler J; Anker SD; Januzzi JL; Panova-Noeva M; Reese-Petersen AL; Sattar N; Schueler E; Pocock SJ; Filippatos G; Packer M; Sumin M; Zannad F;
    Eur J Heart Fail; 2024 Feb; 26(2):274-284. PubMed ID: 38037709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
    [No Abstract]   [Full Text] [Related]  

  • 30. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer.
    Willumsen N; Ali SM; Leitzel K; Drabick JJ; Yee N; Polimera HV; Nagabhairu V; Krecko L; Ali A; Maddukuri A; Moku P; Ali A; Poulose J; Menon H; Pancholy N; Costa L; Karsdal MA; Lipton A
    Sci Rep; 2019 Dec; 9(1):19761. PubMed ID: 31875000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary disease.
    Sand JM; Martinez G; Midjord AK; Karsdal MA; Leeming DJ; Lange P
    Clin Biochem; 2016 Oct; 49(15):1144-1151. PubMed ID: 27614218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
    Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
    RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation.
    Thiele M; Johansen S; Gudmann NS; Madsen B; Kjaergaard M; Nielsen MJ; Leeming DJ; Jacobsen S; Bendtsen F; Møller S; Detlefsen S; Karsdal M; Krag A;
    Aliment Pharmacol Ther; 2021 Oct; 54(8):1070-1080. PubMed ID: 34428307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.
    Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ; Sand JMB
    Respir Res; 2020 Jul; 21(1):202. PubMed ID: 32731895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
    Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
    Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.
    Dobrota R; Jordan S; Juhl P; Maurer B; Wildi L; Bay-Jensen AC; Karsdal MA; Herrick AL; Distler JHW; Allanore Y; Hoffmann-Vold AM; Siebuhr AS; Distler O
    Lancet Rheumatol; 2021 Mar; 3(3):e175-e184. PubMed ID: 38279380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
    Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS
    Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
    Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
    Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
    Vuga LJ; Tedrow JR; Pandit KV; Tan J; Kass DJ; Xue J; Chandra D; Leader JK; Gibson KF; Kaminski N; Sciurba FC; Duncan SR
    Am J Respir Crit Care Med; 2014 Apr; 189(8):966-74. PubMed ID: 24628285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
    Lipton A; Leitzel K; Ali SM; Polimera HV; Nagabhairu V; Marks E; Richardson AE; Krecko L; Ali A; Koestler W; Esteva FJ; Leeming DJ; Karsdal MA; Willumsen N
    Int J Cancer; 2018 Dec; 143(11):3027-3034. PubMed ID: 29923614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.